Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disease Progression”

3,709 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,709 results

Testing effectiveness (Phase 2)UnknownNCT00263471
What this trial is testing

Myopia Progression and the Effect of 7-Methylxanthine

Who this might be right for
Myopia
Trier Research Laboratories 90
Not applicableLooking for participantsNCT06841692
What this trial is testing

Diuretic Testing in Chronic Kidney Disease

Who this might be right for
Kidney Disease, Chronic
Erasmus Medical Center 86
Not applicableUnknownNCT04895007
What this trial is testing

Comparative Evaluation of Covid-19 Vaccines Response

Who this might be right for
COVID-19 Vaccines
Karamanoğlu Mehmetbey University 1,500
Post-approval studies (Phase 4)Study completedNCT01129336
What this trial is testing

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

Who this might be right for
First or Second Line HER2-negative Breast CancerMetastatic Disease Without Bone Metastasis
Novartis Pharmaceuticals 44
Not applicableNot Yet RecruitingNCT06405711
What this trial is testing

To Evaluate the Efficacy and Safety of an Defocus Lens in Slowing the Progression of Myopia

Who this might be right for
Myopia, Progressive
Tianjin Eye Hospital 138
Testing effectiveness (Phase 2)UnknownNCT00839111
What this trial is testing

Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment

Who this might be right for
Colorectal Neoplasms
Fudan University 43
Large-scale testing (Phase 3)Study completedNCT00689936
What this trial is testing

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 1,623
Testing effectiveness (Phase 2)Active Not RecruitingNCT04207944
What this trial is testing

The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

Who this might be right for
IPMNIPMN, Pancreatic
Duke University 100
Not applicableLooking for participantsNCT07278700
What this trial is testing

The Fever Clinic Acute Respiratory Cohort

Who this might be right for
Acute Respiratory InfectionsFebrile IllnessesCommunity-acquired Pneumonia+2 more
Fudan University 1,000
Post-approval studies (Phase 4)Study completedNCT04549415
What this trial is testing

The Influence of Metformin on Chronic Heart Failure Clinical Course in Patients With Prediabetes

Who this might be right for
Chronic Heart FailureCoronary Artery DiseasePreDiabetes
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov 97
Not applicableTemporarily pausedNCT04639635
What this trial is testing

CNGB1 and Allied Disorders

Who this might be right for
Retinitis Pigmentosa Associated With CNGB1 Mutations
Columbia University 20
Not applicableActive Not RecruitingNCT06087718
What this trial is testing

Feasibility of the Maastro Applicator in Rectal Cancer

Who this might be right for
Rectal CancerFeasibilityToxicity+5 more
Maastricht Radiation Oncology 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03999710
What this trial is testing

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerLung CancerNsclc+2 more
Memorial Sloan Kettering Cancer Center 61
Testing effectiveness (Phase 2)Study completedNCT03184090
What this trial is testing

Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC

Who this might be right for
Metastatic Breast Cancer
MedSIR 33
Not applicableLooking for participantsNCT05033990
What this trial is testing

SPIROMICS Study of Early COPD Progression (SOURCE)

Who this might be right for
COPD, Early-Onset
University of Massachusetts, Worcester 1,000
Not applicableUnknownNCT05695118
What this trial is testing

Body Composition and Fatty Liver Disease

Who this might be right for
Fatty Liver
Seoul National University Hospital 150
Not applicableStudy completedNCT01950897
What this trial is testing

Muscle Tissue Bank for Muscular Dystrophy

Who this might be right for
Muscular DystrophiesMuscular Dystrophy
Wake Forest University Health Sciences 21
Testing effectiveness (Phase 2)Study completedNCT02968810
What this trial is testing

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

Who this might be right for
CirrhosisHepatocellular Carcinoma
National Cancer Institute (NCI) 52
Testing effectiveness (Phase 2)Study completedNCT03092518
What this trial is testing

Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology

Who this might be right for
Gastric AdenocarcinomaEsophagogastric JunctionGastric Cancer
National Cancer Institute (NCI) 27
Not applicableEnded earlyNCT06014541
What this trial is testing

Observational Study to Characterize Biomarkers and Disease Progression in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

Who this might be right for
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Ionis Pharmaceuticals, Inc. 29
Next Page